A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 1b Crossover Trial Comparing Two Doses of Ulotaront with Placebo in the Treatment of Narcolepsy-Cataplexy
Sleep Medicine（2023）
Key words
Trace amine-associated receptor 1 (TAAR1),Serotonin (5-hydroxytryptamine) 1A (5-HT1A),Rapid eye movement (REM),Narcolepsy,Cataplexy,Excessive daytime sleepiness (EDS)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined